Department of Cardiology, Austin Health, Melbourne, Australia; Department of Medicine, University of Melbourne, Melbourne, Australia.
Centre of Cardiovascular Research and Education in Therapeutics (CCRE), Monash University, Melbourne, Australia.
Am Heart J. 2019 Jun;212:134-143. doi: 10.1016/j.ahj.2019.02.013. Epub 2019 Mar 5.
Repeat hospitalizations for recurrent acute coronary syndrome (ACS) or unplanned revascularization after acute myocardial infarction (MI) are common, costly and potentially preventable. We aim to describe 10-year trends and identify independent risk factors of these repeat hospitalizations.
We analyzed data from 9615 patients from the Melbourne Interventional Group registry (2005-2014) who underwent percutaneous coronary intervention (PCI) for their index MI and survived to discharge. Patients with ≥1 hospitalization for recurrent ACS events and/or unplanned revascularization in the year after discharge were included in the recurrent coronary hospitalization group. We assessed yearly trends of recurrent coronary events and identified independent predictors using multivariate analysis.
Recurrent coronary hospitalization occurred in 1175 (12.2%) patients. There was a significant decrease in the rate of recurrent ACS hospitalization (15.3%-7.6%, P for trend <.001) and unplanned revascularization (4.2%-2.1%, P for trend = .01), but not in all-cause re-hospitalizations (P for trend = .28). On multivariate analysis, female gender, diabetes mellitus, previous coronary bypass surgery, previous PCI, reduced ejection fraction, heart failure, multi-vessel coronary disease and obstructive sleep apnea were independent predictors of recurrent coronary hospitalizations (all P < .05).
Recurrent hospitalization for ACS or unplanned revascularization has decreased significantly over the past decade. Risk factors for such events are numerous and largely non-modifiable, however they identify a cohort of patients in whom non-culprit vessel PCI in multi-vessel disease, optimization of left ventricular dysfunction and diabetes management may improve outcomes.
复发性急性冠状动脉综合征(ACS)或急性心肌梗死(MI)后计划外血运重建的再次住院治疗较为常见,且费用高昂,还有潜在的可预防因素。我们旨在描述这些再次住院治疗的 10 年趋势,并确定其独立的危险因素。
我们分析了来自墨尔本介入组注册中心(2005-2014 年)的 9615 例接受经皮冠状动脉介入治疗(PCI)的患者的数据,这些患者的指数 MI 经 PCI 治疗后存活至出院。将出院后 1 年内因复发性 ACS 事件和/或计划外血运重建而再次住院的患者纳入复发性冠状动脉住院患者组。我们评估了复发性冠状动脉事件的年趋势,并使用多变量分析确定了独立的预测因素。
1175 例(12.2%)患者发生了复发性冠状动脉住院治疗。复发性 ACS 住院率(15.3%-7.6%,趋势 P<0.001)和计划外血运重建率(4.2%-2.1%,趋势 P=0.01)显著下降,但全因再住院率(趋势 P=0.28)没有变化。多变量分析显示,女性、糖尿病、既往冠状动脉旁路移植术、既往 PCI、射血分数降低、心力衰竭、多支血管病变和阻塞性睡眠呼吸暂停是复发性冠状动脉住院的独立预测因素(均 P<0.05)。
过去十年,复发性 ACS 或计划外血运重建的再次住院治疗显著减少。这些事件的危险因素众多且大部分是不可改变的,但它们确定了一个多支血管疾病中罪犯血管以外 PCI、左心室功能障碍和糖尿病管理优化可能改善结局的患者群体。